Slater D N
Department of Histopathology, Floor E, Royal Hallamshire Hospital, Sheffield S10 2JX, UK.
Br J Dermatol. 2002 Oct;147(4):633-9. doi: 10.1046/j.1365-2133.2002.05050.x.
The World Health Organization (WHO) has published a new consensus classification of tumours of haematopoietic and lymphoid tissue, based on recognizable disease entities defined by clinical and scientific criteria. The WHO does not support the use of stand-alone organ-related classifications, such as for skin. The Royal College of Pathologists (London) has adopted the WHO classification in its minimum dataset for the histopathological reporting of lymphoma and this will be used in the National Health Service Skin Cancer Dataset. The purpose of this review is to highlight the principal primary and secondary cutaneous haematopoietic and lymphoid tumours that are defined in the WHO classification. The review also discusses selected problematical areas in the WHO classification relevant to the skin and contains suggestions to encourage a unified approach in the use of the WHO coded summary. These represent an attempt to facilitate future progress and research in the field of cutaneous lymphoma. They are perceived as possible building-blocks for wider discussion and not as alterations to the classification. The WHO classification has been compared with a road map that indicates directions for future clinical and scientific research.
世界卫生组织（WHO）发布了一份关于造血与淋巴组织肿瘤的新共识分类，该分类基于由临床和科学标准定义的可识别疾病实体。WHO不支持使用单独的与器官相关的分类，如针对皮肤的分类。（伦敦）皇家病理学家学院已在其淋巴瘤组织病理学报告的最小数据集中采用了WHO分类，该分类将用于国民健康服务皮肤癌数据集。本综述的目的是突出WHO分类中定义的主要原发性和继发性皮肤造血与淋巴肿瘤。该综述还讨论了WHO分类中与皮肤相关的选定问题领域，并提出了一些建议，以鼓励在使用WHO编码摘要时采用统一方法。这些建议旨在促进皮肤淋巴瘤领域未来的进展和研究。它们被视为更广泛讨论的可能基石，而非对分类的更改。WHO分类已与一份路线图进行了比较，该路线图指明了未来临床和科学研究的方向。
